Article ID Journal Published Year Pages File Type
9646303 Schizophrenia Research 2005 8 Pages PDF
Abstract
The results provide a better framework for understanding the clinical meaning of the PANSS total score in drug trials of schizophrenia patients with acute exacerbations. Such studies may ideally use at least a 50% reduction from baseline cut-off to define response rather than lower thresholds. In treatment resistant populations, however, even a small improvement can be important, so that a 25% cut-off might be appropriate.
Related Topics
Life Sciences Neuroscience Behavioral Neuroscience
Authors
, , , , , ,